Karuna Therapeutics Inc. (KRTX) Prices 2.08M Share Common Offering at $120/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Karuna Therapeutics Inc. (KRTX) PT Raised to $165 at RBC Capital, Sees Underappreciated De-Risking
March 1, 2021 6:50 AM ESTRBC Capital analyst Brian Abrahams raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $165.00 (from $160.00) while maintaining a Outperform rating.
The analyst comments "Late last week, KRTX reported preliminary qualitative data from its ph.Ib study of lead drug KarXT in... More
Karuna Therapeutics Inc. (KRTX) Announces $200M Proposed Public Offering of Common Stock
March 1, 2021 6:19 AM ESTKaruna Therapeutics, Inc. (NASDAQ: KRTX) (Karuna), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it has commenced an underwritten public offering of $200.0 million of its common stock. Karuna also intends to grant the underwriters a 30-day... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $148 at Oppenheimer
March 1, 2021 5:09 AM ESTOppenheimer analyst Jay Olson raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $148.00 (from $135.00) while maintaining a Outperform rating.... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $150 at Mizuho Securities
February 26, 2021 6:44 AM ESTMizuho Securities analyst Vamil Divan raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $150.00 (from $116.00) while maintaining a Buy rating.... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $175 at Citi
February 26, 2021 5:57 AM ESTCiti analyst Mohit Bansal raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $175.00 (from $115.00) while maintaining a Buy rating.... More
